Filing Details
- Accession Number:
- 0001415889-22-003324
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-24 16:39:25
- Reporting Period:
- 2022-03-23
- Accepted Time:
- 2022-03-24 16:39:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1790340 | Immuneering Corp | IMRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1870062 | J. Benjamin Zeskind | 245 Main Street Second Floor Cambridge MA 02142 | President And Ceo | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2022-03-23 | 3,000 | $8.02 | 2,257,352 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Class A Common Stock | 894,927 | Indirect | See Foonote |
Footnotes
- This transaction was executed in multiple trades through a broker-dealer at prices ranging from $7.92 to $8.10. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares acquired at each price.
- Held by the Benjamin J. Zeskind 2020 Family Trust, where Lisa Schwartz, Dr. Zeskind's spouse, serves as sole trustee.